Blockchain Registration Transaction Record

AHA Launches National Heart Valve Initiative to Save Lives

American Heart Association launches Heart Valve Initiative with Edwards Lifesciences to combat rising heart valve disease affecting 28M globally. New program aims for earlier diagnosis & better treatment.

Heart valve disease represents a silent epidemic affecting millions globally, with many patients remaining undiagnosed until their condition becomes critical. This initiative matters because it addresses a crucial gap in cardiovascular care where delayed diagnosis and treatment can lead to preventable deaths and disability. For the aging population, particularly those over 65 who face increased risk, this coordinated approach could mean earlier detection, more timely interventions, and ultimately longer, healthier lives. The program's focus on standardizing care through hospital certification and professional education ensures that patients receive consistent, evidence-based treatment regardless of where they seek care. By improving systems for identifying and managing heart valve conditions, this initiative has the potential to significantly reduce the 60,000 annual deaths attributed to heart valve disease in the U.S. alone, while also enhancing quality of life for millions living with these conditions.